Andrew C Peters

Title: The Innovations of Andrew C. Peters

Introduction

Andrew C. Peters is a notable inventor based in Yardley, PA, who has made significant contributions to the field of lipid chemistry. He holds two patents that showcase his innovative approach to developing modified ether glyceroglycolipids. His work has implications for medical treatments, particularly in addressing various diseases and disorders.

Latest Patents

Peters' latest patents focus on modified ether glyceroglycolipids. These inventions provide lipids characterized by a glycerol backbone, a hydrocarbon chain that is preferably saturated and contains 16 or 18 carbon atoms, and a methyl group attached to C-2 of the backbone. Additionally, a sugar is attached to C-3 of the glycerol backbone, which can be in either the alpha or beta anomeric configuration. The sugar is modified by altering or substituting one or more of its hydroxyl groups. These ether-lipid-containing compositions are designed for administration to animals, particularly those afflicted with cancers and other diseases.

Career Highlights

Throughout his career, Andrew C. Peters has worked with various organizations, including the Liposome Company, Inc. His innovative work in lipid chemistry has positioned him as a key figure in the development of new therapeutic approaches.

Collaborations

Peters has collaborated with notable individuals in his field, including Robert Bittman and Ravi K. Erukulla. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Andrew C. Peters is a distinguished inventor whose work in modified ether glyceroglycolipids has the potential to impact medical treatments significantly. His contributions to lipid chemistry continue to pave the way for innovative solutions in addressing various health challenges.